Active immunization against hepatitis A virus (HAV) infection in persons >18 mth. Primary immunization. Pre- & post-exposure prophylaxis of individuals at increased risk of infection.
Hypersensitivity. Acute infectious disease or other serious illness. Acute febrile illness w/ temp >37.5°C. Immunological deficiency states. History of anaphylaxis or any other serious allergic reaction to vaccines. Hemophilia A.
Local: Pain at the site of inj; redness; swelling, hematoma, induration/edema; pruritus. Systemic: Fever (>37.5°C axillary); asthenia/drowsiness; headache, myalgia/arthralgia; GI disorders; behavioural changes, skin disorders.
Sign Out
